Comparison of neuromuscular blockade in upper facial and hypothenar muscles.
Facial and hand muscles are used frequently for monitoring neuromuscular blockade. Therefore, we compared changes in electrically evoked muscle potential magnitude in upper facial and hypothenar muscles after fixed doses of neuromuscular blockers (succinylcholine, 750 micrograms/kg; pancuronium, 70 micrograms/kg; vecuronium, 50 micrograms/kg; and atracurium, 300 micrograms/kg). Face-hand comparisons were made in both anesthetized (nitrous oxide/narcotic, n = 51) and comatose (closed-head injuries, n = 5) patients. In 24 anesthetized patients, complete blockade of the hypothenar muscles prevented quantitative comparison. In the remaining 27 patients, the relaxant effect (as determined by the percentage change from prerelaxant baseline muscle potentials) was significantly smaller (P less than 0.0001) in the upper facial muscles (65 +/- 24% versus 92 +/- 8%, mean +/- SD). All four evoked muscle responses to train-of-four stimulation were detectable in upper facial muscles of the 19 patients receiving non-depolarizing neuromuscular blocking drugs; this pattern was seen in hand muscles of only 7 patients (P less than 0.001). The neuromuscular blockade in both the hand (49 +/- 54%) and the upper facial area (68 +/- 28%, P greater than 0.05) of comatose patients was smaller and more variable than that seen during anesthesia. These results illustrate the value of quantitative monitoring of neuromuscular function, especially during highly variable and unpredictable drug-induced blockade in the comatose state. We conclude that during narcotic-based anesthesia the upper facial and hand muscles are differentially sensitive to commonly used neuromuscular blockers.
Paloheimo
M P
MP
Department of Anesthesiology, University of Louisville, School of Medicine, KY 40292.
Wilson
R C
RC
Edmonds
H L
HL
Lucas
L F
LF
Triantafillou
A N
AN
D000768:Anesthesia, General; D003128:Coma / Q000503:physiopathology; D004576:Electromyography; D005071:Evoked Potentials / Q000187:drug effects; D005152:Facial Muscles / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D006225:Hand / Q000502:physiology / Q000503:physiopathology; D006801:Humans; D009132:Muscles / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*
D009466:Neuromuscular Blocking Agents